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Cryptic-Plasmid-Free Gonococci May Contribute to Failure of cppB Gene-Based
Assays To Confirm Results of BD ProbeTEC PCR for Identification
of Neisseria gonorrhoeae
We note the recent article by Koenig et al. (3) which de-
scribes discordance between results obtained with the BD
ProbeTEC ET System (BDPT) and a cppB gene-based PCR
assay for the detection of Neisseria gonorrhoeae. Overall, 22.6%
of BDPT-positive assays were not confirmed by the cppB gene-
based PCR, but agreement was particularly low in those sam-
ples producing a reduced method-other-than-acceleration
score with the BDPT PCR. The BDPT PCR has been found to
cross-react with commensal Neisseria species (5), but such
cross-reactions may not adequately explain the high level of
nonconfirmed BDPT PCR-positive results obtained in this
study. Even with samples with method-other-than-acceleration
scores in higher ranges (20,000), between 6 and 15.5% of
positive BDPT PCR results could not be confirmed with the
cppB gene-based assay. The authors discussed, among a num-
ber of potential reasons for the discrepancy, the possibility that
the presence of gonococci lacking the cryptic plasmid where
the cppB gene is located may account for this difference. This
possibility was disregarded on the basis of studies reporting
that 96% of gonococci contained a cryptic plasmid and that
even where this plasmid was absent, amplification of a cppB
gene sequence replicated in the chromosome may produce the
required positive result.
Recent studies suggest this confidence in cppB gene-based
assays may be misplaced. We have recently reported that 10%
of culture-positive gonococci were cppB gene-based PCR neg-
ative but positive in other assays, including the BDPT PCR (4;
J. Tapsall, A. Limnios, I. Carter, G. Lum, K. Freeman, and T.
Sloots, Abstr. 15th Biennial Congr. Int. Soc. Sex. Transm. Dis.
Res., abstr. 0129, 2003). It is known that cryptic-plasmid-free
gonococci may vary widely in prevalence in time and place and
occur among diverse gonococcal subtypes and specifically that
a high incidence of plasmid-free gonococci has been docu-
mented in Germany (1, 4). Further, considerable recombina-
tion occurs within the DNA of the plasmid and some cppB
gene sequences present in the chromosome were incomplete
and in low copy numbers (6, 7). It is thus not surprising that
some decreased sensitivity with cppB gene-based nucleic acid
amplification, arising from absent, altered, or low copy num-
bers of the chosen sequence, has now been acknowledged with
different forms of this test (2, 9).
We thus concluded (4) that other nucleic acid amplification
(8, 9) are preferable to the problematic cppB gene-based as-
says. If the cppB gene-based PCR is employed as either a
diagnostic or supplemental assay for diagnosis of gonorrhoeae,
its use should be contingent upon ongoing assessment of the
proportion of gonococci lacking this target site by means of
evaluations which directly assess both culture and PCR per-
formance. It is therefore suggested that Koenig et al. should
consider conducting such a study and also that it is possible
that an additional explanation for the discrepant results is that
some of the supposedly false-positive results in the BDPT PCR
may have been true positives but not recognized by a false-
negative cppB gene-based PCR.
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Ed. Note: The authors of the published article did not feel a response was
warranted at this time.
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